STAA - STAAR Surgical Co Stock Price, Fair Value and News

$26.66+0.03 (+0.11%)

Delayed as of 22 Nov 2024, 10:57 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

STAA Price Action

Last 7 days

-2.5%

Last 30 days

-12.5%

Last 90 days

-20.0%

Trailing 12 Months

-21.0%

STAA RSI Chart

STAA Valuation

Market Cap

1.3B

Price/Earnings (Trailing)

60.26

Price/Sales (Trailing)

3.85

EV/EBITDA

28.07

Price/Free Cashflow

49.9

STAA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

STAA Fundamentals

STAA Revenue

Revenue (TTM)

341.2M

Rev. Growth (Yr)

10.31%

Rev. Growth (Qtr)

-10.52%

STAA Earnings

Earnings (TTM)

21.8M

Earnings Growth (Yr)

107.18%

Earnings Growth (Qtr)

35.25%

STAA Profitability

EBT Margin

10.26%

Return on Equity

5.09%

Return on Assets

4.05%

Free Cashflow Yield

STAA Investor Care

Shares Dilution (1Y)

0.94%

Diluted EPS (TTM)

0.44

STAA Alerts

Big jump in Earnings (Y/Y)

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	326.2M	332.9M	341.2M	0
2023	294.7M	305.9M	310.2M	322.4M
2022	242.9M	261.7M	279.3M	284.4M
2021	179.0M	206.2M	217.5M	230.5M
2020	152.8M	148.3M	156.3M	163.5M
2019	129.4M	135.2M	142.5M	150.2M
2018	97.4M	109.3M	117.6M	124.0M
2017	83.5M	84.5M	87.9M	90.6M
2016	77.5M	79.9M	81.2M	82.4M
2015	73.7M	72.3M	72.8M	77.1M
2014	74.4M	76.3M	77.4M	75.0M
2013	66.3M	68.5M	69.7M	72.2M
2012	63.4M	63.1M	63.7M	63.8M
2011	56.0M	58.7M	60.8M	62.8M
2010	0	52.4M	53.7M	55.0M
2009	0	0	0	51.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

CEO	Mr. Thomas G. Frinzi
WEBSITE	staar.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	882

STAAR Surgical Co Frequently Asked Questions

What is the ticker symbol for STAAR Surgical Co? What does STAA stand for in stocks?

STAA is the stock ticker symbol of STAAR Surgical Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of STAAR Surgical Co (STAA)?

As of Thu Nov 21 2024, market cap of STAAR Surgical Co is 1.31 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of STAA stock?

You can check STAA's fair value in chart for subscribers.

Is STAAR Surgical Co a good stock to buy?

The fair value guage provides a quick view whether STAA is over valued or under valued. Whether STAAR Surgical Co is cheap or expensive depends on the assumptions which impact STAAR Surgical Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STAA.

What is STAAR Surgical Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Nov 21 2024, STAA's PE ratio (Price to Earnings) is 60.26 and Price to Sales (PS) ratio is 3.85. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STAA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on STAAR Surgical Co's stock?

In the past 10 years, STAAR Surgical Co has provided 0.107 (multiply by 100 for percentage) rate of return.